GLABF
Price
$0.61
Change
-$0.02 (-3.17%)
Updated
Jun 18 closing price
Capitalization
43.55M
VANI
Price
$1.32
Change
+$0.01 (+0.76%)
Updated
Jun 27 closing price
Capitalization
77.61M
51 days until earnings call
Interact to see
Advertisement

GLABF vs VANI

Header iconGLABF vs VANI Comparison
Open Charts GLABF vs VANIBanner chart's image
GEMINA LABORATORIES
Price$0.61
Change-$0.02 (-3.17%)
Volume$1K
Capitalization43.55M
Vivani Medical
Price$1.32
Change+$0.01 (+0.76%)
Volume$126.17K
Capitalization77.61M
GLABF vs VANI Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. VANI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and VANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GLABF: $0.61 vs. VANI: $1.32)
Brand notoriety: GLABF and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 15% vs. VANI: 125%
Market capitalization -- GLABF: $43.55M vs. VANI: $77.61M
GLABF [@Biotechnology] is valued at $43.55M. VANI’s [@Biotechnology] market capitalization is $77.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 1 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 1 green, 4 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLABF and VANI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 4 TA indicator(s) are bullish while VANI’s TA Score has 4 bullish TA indicator(s).

  • GLABF’s TA Score: 4 bullish, 2 bearish.
  • VANI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLABF is a better buy in the short-term than VANI.

Price Growth

GLABF (@Biotechnology) experienced а 0.00% price change this week, while VANI (@Biotechnology) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VANI is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($77.6M) has a higher market cap than GLABF($43.6M). VANI YTD gains are higher at: 13.793 vs. GLABF (12.029). GLABF has higher annual earnings (EBITDA): -3.46M vs. VANI (-24.6M). VANI has more cash in the bank: 13M vs. GLABF (41.6K). GLABF has less debt than VANI: GLABF (1.46M) vs VANI (18.9M). GLABF (0) and VANI (0) have equivalent revenues.
GLABFVANIGLABF / VANI
Capitalization43.6M77.6M56%
EBITDA-3.46M-24.6M14%
Gain YTD12.02913.79387%
P/E RatioN/AN/A-
Revenue00-
Total Cash41.6K13M0%
Total Debt1.46M18.9M8%
FUNDAMENTALS RATINGS
VANI: Fundamental Ratings
VANI
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVANI
RSI
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
45%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
45%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYSNY3.52N/A
N/A
Hysan Development Co., Ltd.
JXHGF4.91N/A
N/A
Eneos Holdings Inc.
NICXF0.25N/A
N/A
Nicox S.A.
FMCCM18.25N/A
N/A
Freddie Mac
RAMPF8.70-0.01
-0.15%
POLARIS RENEWABLE ENERGY INC.

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
33%
Loosely correlated
N/A
VANI - GLABF
29%
Poorly correlated
+0.76%
WHWK - GLABF
23%
Poorly correlated
+1.58%
VKTX - GLABF
20%
Poorly correlated
-5.86%
ENTO - GLABF
8%
Poorly correlated
-12.87%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
+0.76%
VTVT - VANI
59%
Loosely correlated
-6.82%
ENVB - VANI
41%
Loosely correlated
-2.36%
GLSI - VANI
34%
Loosely correlated
N/A
NRIX - VANI
33%
Loosely correlated
+0.17%
ARWR - VANI
32%
Poorly correlated
+0.06%
More